CAS 210110-90-0
:3,4,5-Pipéridinetriol, 1-butyl-2-(hydroxyméthyl)-, chlorhydrate (1:1), (2R,3R,4R,5S)-
- 3,4,5-Piperidinetriol, 1-butyl-2-(hydroxymethyl)-, hydrochloride (1:1), (2R,3R,4R,5S)-
- 3,4,5-Piperidinetriol, 1-butyl-2-(hydroxymethyl)-, hydrochloride, (2R,3R,4R,5S)-
- Miglustat HCl
- Miglustat hydrochloride
3,4,5-Piperidinetriol, 1-butyl-2-(hydroxymethyl)-, hydrochloride (1:1), (2R,3R,4R,5S)-
CAS :Formule :C10H22ClNO4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :255.7390(2R,3R,4R,5S)-1-Butyl-2-(hydroxymethyl)piperidine-3,4,5-triol hydrochloride
CAS :(2R,3R,4R,5S)-1-Butyl-2-(hydroxymethyl)piperidine-3,4,5-triol hydrochlorideDegré de pureté :98%Couleur et forme :PowderMasse moléculaire :255.74g/molMiglustat hydrochloride
CAS :Miglustat hydrochlorideDegré de pureté :≥98%Masse moléculaire :255.74g/molMiglustat HCl
CAS :Formule :C10H21NO4·HClCouleur et forme :White To Off-White SolidMasse moléculaire :219.28 36.46N-(n-Butyl)-1-deoxynojirimycin hydrochloride
CAS :N-(n-Butyl)-1-deoxynojirimycin hydrochlorideDegré de pureté :>99%Masse moléculaire :255.74g/molN-Butyldeoxynojirimycin Hydrochloride
CAS :Produit contrôléApplications An inhibitor of a-glucosidase 1 as well as being an inhibitor of HIV cytopathicity. N-Butyldeoxynojirimycin has recently been used to retard lipid storage in the central nervous system of an animal model of Tay-Sachs disease.1-Deoxynojirimycin derivatives as selective inhibitors of glucosylceramide metabolism in man.
References Hettkamp, H., et al.: Eur. J. Biochem., 142, 85 (1984), Szumilo, T., et al.: Arch. Biochem. Biophys., 247, 261 (1986), Fleet, G.W.J., et al.: FEBS Letters, 237, Number 1,2, 128 (1988), Kolter, T., et al.: Angew. Chem. Int. Ed. Engl., 36, 1955 (1997),Formule :C10H21NO4·ClHCouleur et forme :NeatMasse moléculaire :255.74N-Butyldeoxynojirimycin hydrochloride
CAS :Competitive inhibitor of ceramide-glycosyltransferase used for substrate reduction therapy in lysosomal storage disorders. It inhibits glucosylceramide synthase, which catalyses the initial step in glycosphingolipid biosynthetic pathway. This compound delays the onset of symptoms in type 1 Gaucher disease, Sandhoff disease and Tay-Sachs disease. It also reduces brain abnormalities in mucolipidosis type IV.
Formule :C10H21NO4•HClDegré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :255.74 g/molMiglustat hydrochloride
CAS :Miglustat hydrochloride (N-Butyldeoxynojirimycin hydrochloride) is an inhibitor of glucosylceramide synthase and can be used for studies about Type I GaucherFormule :C10H22ClNO4Degré de pureté :99.85%Couleur et forme :SolidMasse moléculaire :255.74Ref: TM-TQ0155
1mg38,00€5mg84,00€10mg130,00€25mg245,00€50mg385,00€100mg557,00€200mg790,00€1mL*10mM (DMSO)93,00€






